BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15126571)

  • 1. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
    Gaasenbeek M; Powell BL; Sovio U; Haddad L; Gharani N; Bennett A; Groves CJ; Rush K; Goh MJ; Conway GS; Ruokonen A; Martikainen H; Pouta A; Taponen S; Hartikainen AL; Halford S; Järvelin MR; Franks S; McCarthy MI
    J Clin Endocrinol Metab; 2004 May; 89(5):2408-13. PubMed ID: 15126571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.
    Ferk P; Gersak K; Teran N
    J Assist Reprod Genet; 2006 Jan; 23(1):29-32. PubMed ID: 16391898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism.
    San Millán JL; Sancho J; Calvo RM; Escobar-Morreale HF
    Fertil Steril; 2001 Apr; 75(4):797-802. PubMed ID: 11287037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
    Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
    Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].
    Prazáková S; Vanková M; Bradnová O; Lukásová P; Vcelák J; Dvoráková K; Vondra K; Vrbíková J; Bendlová B
    Cas Lek Cesk; 2010; 149(11):520-5. PubMed ID: 21391350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microsatellite polymorphism of (tttta) n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome].
    Wang Y; Wu XK; Cao YX; Yi L; Zou Y; Qu JW; Hou LH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3396-400. PubMed ID: 16409859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women.
    Hao CF; Bao HC; Zhang N; Gu HF; Chen ZJ
    Neuro Endocrinol Lett; 2009 Mar; 30(1):56-60. PubMed ID: 19300392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome.
    Wang Y; Wu X; Cao Y; Yi L; Chen J
    Fertil Steril; 2006 Jul; 86(1):223-6. PubMed ID: 16764871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters.
    Daneshmand S; Weitsman SR; Navab A; Jakimiuk AJ; Magoffin DA
    Fertil Steril; 2002 Feb; 77(2):274-80. PubMed ID: 11821083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism of CYP11A1 gene in Chinese patients with polycystic ovarian syndrome].
    Gao GH; Cao YX; Yi L; Wei ZL; Xu YP; Yang C
    Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):191-6. PubMed ID: 20450755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
    Zheng W; Gao YT; Shu XO; Wen W; Cai Q; Dai Q; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):709-14. PubMed ID: 15159300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Bartzis MI; Bergiele AT; Tsianateli TC; Kouli CR
    Fertil Steril; 2000 Apr; 73(4):735-41. PubMed ID: 10731534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
    Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
    Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits.
    Powell BL; Haddad L; Bennett A; Gharani N; Sovio U; Groves CJ; Rush K; Goh MJ; Conway GS; Ruokonen A; Martikainen H; Pouta A; Taponen S; Hartikainen AL; Halford S; Zeggini E; Järvelin MR; Franks S; McCarthy MI
    J Clin Endocrinol Metab; 2005 May; 90(5):2988-93. PubMed ID: 15705917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.
    Xita N; Tsatsoulis A; Chatzikyriakidou A; Georgiou I
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5976-80. PubMed ID: 14671199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of pentanucleotide repeats (tttta)n in the promoter of CYP11A1 and their relationships to polycystic ovary syndrome (PCOS) risk: a meta-analysis.
    Yu M; Feng R; Sun X; Wang H; Wang H; Sang Q; Jin L; He L; Wang L
    Mol Biol Rep; 2014 Jul; 41(7):4435-45. PubMed ID: 24610422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
    Barber TM; Bennett AJ; Gloyn AL; Groves CJ; Sovio U; Ruokonen A; Martikainen H; Pouta A; Taponen S; Weedon MN; Hartikainen AL; Wass JA; Järvelin MR; Zeggini E; Franks S; McCarthy MI
    Eur J Hum Genet; 2007 Jun; 15(6):679-84. PubMed ID: 17342155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome.
    Walch K; Grimm C; Zeillinger R; Huber JC; Nagele F; Hefler LA
    Fertil Steril; 2004 Jun; 81(6):1638-41. PubMed ID: 15193488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
    Strauss JF
    Ann N Y Acad Sci; 2003 Nov; 997():42-8. PubMed ID: 14644808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.